Biopharmaceutical classification system: A strategic tool for oral drug delivery technology

Asian Journal of Pharmaceutics

Volumn 3, Issue 2, 2009, Pages 76-81

  Sachan, Nikhil K ^a   Bhattacharya, A ^b   Pushkar, Seema ^a   Mishra, A ^c  

^a CSJM UNIVERSITY   (India)

^b DIBRUGARH UNIVERSITY   (India)

^c AND College of Pharmacy   (India)

Author keywords

Biopharmaceutical; Biopharmaceutical classification system; Drug delivery; Preformulation

Indexed keywords

ACICLOVIR; ALENDRONIC ACID; CAPTOPRIL; CEFUROXIME; DILTIAZEM; ENALAPRILAT; FUROSEMIDE; KETOCONAZOLE; MEFENAMIC ACID; METOPROLOL; NEOMYCIN; NEW DRUG; NIFEDIPINE; NISOLDIPINE; PEPTIDE; PROPRANOLOL DERIVATIVE; RANITIDINE; SURFACTANT; TOBRAMYCIN; VERAPAMIL;

CONTROLLED DRUG RELEASE; DRUG DELIVERY SYSTEM; DRUG PENETRATION; DRUG SOLUBILITY; MEDICAL TECHNOLOGY; REVIEW;

EID: 77953391754     PISSN: 09738398     EISSN: 1998409X     Source Type: Journal    
DOI: 10.4103/0973-8398.55042     Document Type: Review

References (23)

1. Khan GM. Controlled release oral dosage forms: Some recent advances in matrix type drug delivery systems. The Science 2001;1:350-354
2. Sachan NK, Singh D. Evaluation of dried pulp from Carica papaya fruits as disintegrating agents in the formulation of metformin hydrochloride dispersible tablets. Journal of Assam Science Society 2006;46:20-22
3. Amidon GL, Lennerlas H, Shah VP, Crison JR. A theoretical basis for a biopharmaceutic drug classification: The correlation of in vitro drug product dissolution and in vivo bioavailability. Pharm Res 1995;12:413-420
4. Dressman J, Butler J, Hempenstall J, Reppas C. The BCS: Where Do We Go from Here? Pharmaceutical Technology 2001; 7:68-76. Available: www.pharmaportal.com
5. Center for drug evaluation, FDA "Guidance for Industry on Dissolution Testing of Immediate Release Solid Oral Dosage forms" 1997.
6. Center for drug evaluation, FDA "Guidance for Industry on the Waiver of in vivo Bioavailability and Bioequivalence for Immediate Release Solid Oral Dosage forms based on Biopharmaceutical Classification system" 2000.
7. Johnson SR, Zheng Weifan. Recent progress in computational prediction of aqueous solubility and absorption. AAPS J 2006;8 :E27-40.
8. Sharma, J.L. Dictionary of Chemistry. New Delhi India: CBS Publishers and Distributors; 1997. p. 558-560
9. Ahuja, A., Khar, R.K. and Ali, J. Dosage Form Design. 1st ed. N.D. India: Birla Publications Pvt. Ltd.; 2004. p. 3-11.
10. Yu LX, Carlin AS, Hussain AS. Feasibility study of intrinsic dissolution rate as an alternative method to determine BCS solubility membership. AAPS annual meeting 2000.
11. Draft Guidance for Industry, "Waiver of in vivo Bioavailability and Bioequivalence Studies for Immediate Release Solid Oral Dosage Forms containing certain Active Moieties/Active Ingredients based on a Biopharmaceutic Classification System". CDER/FDA 1999.
12. British Pharmacopoeia Electronic version: Appendix I D. Buffer Solutions. London: The Stationary Office; 2003.
13. Devane J. Oral drug delivery technology: Addressing the solubility/ permeability paradigm, Pharmaceutical Technology. 1998; 11:68-74.
14. Dressman J.B. Physiological aspects of the design of dissolution tests, in: Amidon G, Robinson J. Williams R. (eds.), Scientific foundation for regulating drug product quality. Alexandria, VA: AAPS Press. 1997;155-165
15. Lobenberg R, Amidon GL. Modern bioavailability, bioequivalence and biopharmaceutics classification system. New scientific approaches to international regulatory standards. Eur J Pharm Biopharm 2000; 50:3-12.
16. Rinaki E, Valsami G, Macheras P. Quantitative biopharmaceutics classification system: The central role of dose/solubility ratio. Pharm Res 2003;20:1917-1925
17. Bergström CA, Strafford M, Lazorova L, Avdeef A, Luthman K, Artursson P. Absorption classification of oral drugs based on molecular surface properties. J Med Chem 2003;46:558-570
18. Mirja, T. and Gray V.A. Meeting report: Conference on Dissolution, Bioequivalence and Bioavailability. Dissolution Technology 2004;11:25-28
19. Verma RK, Garg S. Current status of drug delivery technologies and future directions. Pharmaceutical Technology (online) 2001; 25(2):1-14.
20. Jorgensen WL, Duffy EM. Prediction of drug solubility from structure. Adv Drug Deliv Rev 2002;54:355-366
21. LobelL M, Sivrajah V. In silico prediction of aqueous solubility, human plasma protein binding and volume of distribution of compounds from calculated pKa and AlogP98 values. Mol Divers 2003;7:69-87.
22. Lipinsky CA, Lombordo F, Dominy BW, Feeney PJ. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Deliv Rev 1997;23:3-26.
23. Wikling IR, Prior DV. Remote controlled capsules in human drug absorption (HAD) studies. Crit Rev Ther Drug Carrier Syst 2003;20:405-431